Skip to content
value.today

Cingulate Inc. vs Pharmicell Co., Ltd.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Pharmicell Co., Ltd. is the larger company by market value: $514 M against $83 M for Cingulate Inc., 6.2 times as much (market caps of Oct 28, 2026 for Cingulate Inc. and Aug 1, 2026 for Pharmicell Co., Ltd.). Pharmicell Co., Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.

Market value, the same start = 100

From Dec 2022: how each one's value moved, whatever its size.

01883765647522023202420252026Cingulate Inc. 752Pharmicell Co., Ltd. 95

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureCingulate Inc.
CING · #19,456 in the world
Pharmicell Co., Ltd.
005690.KS · #12,422 in the world
Profile
Country🇺🇸 USA🇰🇷 South Korea
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded——
Size
Market cap$83 M$514 M
Net income$-22 M—
Valuation
Price to book33.0×—
Free cash flow yield-21.0%—
Profitability
Return on equity-450.4%—
Financial strength
Interest cover-22.2×—
Altman Z-score zone——
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Aug 2026

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, Cingulate Inc. or Pharmicell Co., Ltd.?

Pharmicell Co., Ltd. is the larger company by market value: $514 M against $83 M for Cingulate Inc., 6.2 times as much (market caps of Oct 28, 2026 for Cingulate Inc. and Aug 1, 2026 for Pharmicell Co., Ltd.). Pharmicell Co., Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.

Sources#

Every figure on this page comes from these, with the date shown next to it.